It took more than two years for deputy director of nursing Patricia Yong and her intensive care unit (ICU) nurses to finally regain their footing after the Covid-19 pandemic upended their workflows and worsened the manpower strain in healthcare. “Experience is always...
Travel restrictions during the pandemic also meant that foreign nurses were separated, often for years, from their loved ones.
Malaysian Ng Sook Ting, a senior staff nurse at Khoo Teck Puat Hospital’s acute and emergency care department. PHOTO: KHOO TECK PUAT HOSPITALnurses had to take turns to return home, recalled Ms Ng, who will also receive the Commendation Medal. Foreign nurses make up almost 30 per cent of Singapore’s registered nurses, and about 40 per cent of enrolled nurses.
Singapore expects to employ about 4,000 more nurses by the end of 2023 to boost the nursing workforce.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
‘Experience is always a teacher’: What nurses have learnt after three years of Covid-19Despite multiple challenges, they adapted and feel prepared for the next wave or pandemic. Read more at straitstimes.com.
続きを読む »
'I saw a different side to my dad': Ex-accounts manager takes over yong tau foo stall after dad gets into accidentThis man quit his corporate job to start a business, but his plans took a different turn after his dad got into an accident last month. Alvan Poa decided to take over his father's yong tau foo stall in Jurong West and keep it running. The 33-year-old shared a glimpse of his new life as a hawker in a TikTok...
続きを読む »
China in talks with Pfizer for generic Covid-19 drug: SourcesHONG KONG/BEIJING – China is in talks with Pfizer Inc to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 antiviral drug Paxlovid in China, three sources told Reuters. China's medical products regulator – the National Medical Products Administration (NMPA) – has been leading the talks with Pfizer since...
続きを読む »
China-made mRNA COVID-19 vaccine starts trial productionSHANGHAI: China's CanSino Biologics has entered the 'test production phase' for its COVID-19 mRNA booster vaccine, the company said in a post on its social media account late on Thursday (Jan 5). The vaccine, known as CS-2034, targets new Omicron variants of the virus, which are responsible for the vast ma
続きを読む »
China’s Covid-19 surge threatens villages as Chinese New Year approachesChina is bracing for an onslaught of infections in its fragile countryside. Read more at straitstimes.com.
続きを読む »
China in talks with Pfizer for generic Covid-19 drug: SourcesBeijing is keen to finalise licensing deal terms before the Lunar New Year which begins on Jan 22. Read more at straitstimes.com.
続きを読む »